[Table ofntents PART I 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 A. Selected Financialta 4 B.pitalization and Indebtedness 8 C. Reasons for the Offer and Use of Proceeds 8 D. Risk Factors] [List of Subsidiaries Name Jurisdiction Chinard Blood Servicesrporationyman Islands China Stem Cellss Limitedyman Islands Beijing Jiachenhong Biological Technologies Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Peoples Republic of China Zhejiang Lukou Biotechnology Peoples Republic of China China Stem Cells (East)mpany Limited] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certification I,bert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification CHINARD BLOODRPORATION July 31, 2012 Ting Zheng Chief Executive Officer July 31, 2012bert Chen Chief Financial Officer (Principal Financial and Accounting Officer) v317907_ex13-1.htm 5 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors Chinard Bloodrporation: Hong Kong, China July 31, 2012 v317907_ex15-1.htm 6 EX-15.1]